Nothing Special   »   [go: up one dir, main page]

HK1216891A1 - 苔蘚素組合物、其製備方法和用途 - Google Patents

苔蘚素組合物、其製備方法和用途

Info

Publication number
HK1216891A1
HK1216891A1 HK16104870.9A HK16104870A HK1216891A1 HK 1216891 A1 HK1216891 A1 HK 1216891A1 HK 16104870 A HK16104870 A HK 16104870A HK 1216891 A1 HK1216891 A1 HK 1216891A1
Authority
HK
Hong Kong
Prior art keywords
bryoid
compositions
making
methods
bryoid compositions
Prior art date
Application number
HK16104870.9A
Other languages
English (en)
Inventor
Trevor Percival Castor
Original Assignee
Aphios Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aphios Corp filed Critical Aphios Corp
Publication of HK1216891A1 publication Critical patent/HK1216891A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16104870.9A 2012-11-27 2016-04-28 苔蘚素組合物、其製備方法和用途 HK1216891A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261730227P 2012-11-27 2012-11-27
PCT/US2013/072070 WO2014085491A2 (en) 2012-11-27 2013-11-26 Bryoid compositions, methods of making and use thereof

Publications (1)

Publication Number Publication Date
HK1216891A1 true HK1216891A1 (zh) 2016-12-09

Family

ID=50828594

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104870.9A HK1216891A1 (zh) 2012-11-27 2016-04-28 苔蘚素組合物、其製備方法和用途

Country Status (6)

Country Link
US (4) US20150291616A1 (zh)
EP (1) EP2925315B1 (zh)
JP (1) JP6440628B2 (zh)
CN (2) CN105008342B (zh)
HK (1) HK1216891A1 (zh)
WO (1) WO2014085491A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9994585B2 (en) 2007-12-31 2018-06-12 Aphios Corporation Transplantation therapies
US9034347B2 (en) 2011-12-19 2015-05-19 Arphios Corporation Drug delivery system and method for the treatment of neuro-degenerative disease
US10828276B2 (en) 2012-11-28 2020-11-10 Aphios Corporation Combination therapeutics and methods for the treatment of neurodegenerative and other diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833257A (en) * 1986-07-28 1989-05-23 Arizona Board Of Regents Compositions of matter and methods of using same
US6221153B1 (en) * 1998-06-09 2001-04-24 Trevor Percival Castor Method for producing large crystals of complex molecules
WO2001040214A1 (en) * 1999-11-30 2001-06-07 The Board Of Trustees Of The Leland Stanford Junior University Bryostatin analogues, synthetic methods and uses
EP1551387A4 (en) * 2002-07-02 2007-10-10 Brni Neurosciences Inst PKC ACTIVATION AS A MEANS TO GAIN THE SAPP-A SECRETION AND IMPROVE THE COGNITION USING BRYOSTATIN-TYPE COMPOUNDS
EP2283023A2 (en) * 2008-04-16 2011-02-16 University of Utah Research Foundation Bryostatin analogues and methods of making and using thereof

Also Published As

Publication number Publication date
EP2925315B1 (en) 2019-01-16
CN105008342A (zh) 2015-10-28
US20230250107A1 (en) 2023-08-10
US20210269453A1 (en) 2021-09-02
US20150291616A1 (en) 2015-10-15
US11639359B2 (en) 2023-05-02
US10954248B2 (en) 2021-03-23
CN109331013B (zh) 2022-02-01
EP2925315A2 (en) 2015-10-07
CN105008342B (zh) 2018-10-19
JP2016501224A (ja) 2016-01-18
US20190194222A1 (en) 2019-06-27
WO2014085491A3 (en) 2015-07-16
EP2925315A4 (en) 2016-06-29
WO2014085491A2 (en) 2014-06-05
CN109331013A (zh) 2019-02-15
JP6440628B2 (ja) 2018-12-19

Similar Documents

Publication Publication Date Title
IL250824A0 (en) Certain amino-pyrimidines, their assemblies, and methods of using them
HK1207001A1 (zh) 免疫刺激性組合物及其使用方法
HK1204330A1 (zh) 因子 組合物及其製備和使用方法
EP2836212A4 (en) NOVEL COMPOSITIONS AND METHOD
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
SG11201502264SA (en) Stable metal compounds, their compositions and methods of their use
HK1207824A1 (zh) 多形體組合物、製備方法及其應用
HK1209031A1 (zh) 多糖組合物及使用方法
GB201315350D0 (en) Methods and compositions
GB201315347D0 (en) Methods and compositions
EP2807256A4 (en) MYONECTIN (CTRP15), COMPOSITION COMPRISING SAME AND METHODS OF USE
HK1216891A1 (zh) 苔蘚素組合物、其製備方法和用途
EP2800568A4 (en) COMPOSITIONS, USE METHOD AND TREATMENT METHOD THEREFOR
EP2838543A4 (en) IMMUNOSTIMULANT COMPOSITIONS AND METHODS OF MAKING
EP2834635A4 (en) COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR
HK1213501A1 (zh) 致孔劑組合物、製備方法及用途
EP2841164A4 (en) COMPOSITIONS AND USE PROCEDURES FOR THE SKIN
GB201219884D0 (en) New composition and preparation thereof
AU2012901658A0 (en) Compositions and methods of use